Purchase Order 75N92025P00327

Award Date 9/10/25
Potential Completion Date 10/9/25
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $13,265.25 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the supply of antibodies and kits to support cell isolation research that may affect the immune system. Biolegend is a specialized supplier of products used in immunology, oncology, neuroscience, and cell biology...
The federal contract award is for the procurement of biomedical reagents, antibodies, proteins, and other products from Biolegend, Inc. to support research efforts across multiple federal agencies, particularly within the Department of Health and Human Services (HHS). The $27,489.00 firm-fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under HHS. Biolegend is a for-profit manufacturer and...
This $9,343.50 firm-fixed-price purchase order was awarded to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award supports Biolegend's provision of specialized products, including oligonucleotide-tagged...
This is a firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and research products. The $23,028.75 contract is for the provision of CITEsequencing kits to support staining and labeling research being conducted by the NHLBI DIR Wiley Lab. The award has no set-aside designation and is not associated with a larger...
This is a $14,856.75 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The award is for the provision of reagents and kits, with an ultimate completion date of May 28, 2025. Biolegend has previously served as a subcontractor to Parsons Government Services Inc. on...
This is a $18,328.50 firm-fixed-price purchase order contract awarded to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies, by the National Institutes of Health (NIH) Clinical Center. The contract is for the provision of reagents and kits to support various research efforts across disease areas including COVID-19, multiple sclerosis, infectious diseases, allergies, immunology, oncology, and bone marrow disorders. Biolegend has a history of federal awards with the...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products for life science research and drug discovery. The $3,500.51 contract is to provide a variety of specialized reagents and products, such as oligonucleotide-tagged antibodies, TotalSeq antibody panels, and custom human antibody panels, to support research initiatives...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The $16,199.95 contract is for the delivery of BIOLEGEND antibodies to support NIAID's research initiatives, which may include studies related to COVID-19, immunology, and other disease areas. The contract does not...
This is a firm-fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other life science research products. The contract, valued at $11,120.50, is to provide antibodies to the NHLBI's Division of Intramural Research, Center for Comparative Medicine and Pathobiology, to assess antigens on the surface...
Biolegend, Inc. has been awarded a firm fixed price purchase order valued at ten thousand five hundred sixteen dollars and fifty cents ($10,516.50) by the Department of Health and Human Services' National Institutes of Health Clinical Center. The contract calls for Biolegend to supply antibodies for the Strich Laboratory's clinical trial investigating bacterial sepsis. No set-aside designation was used for this award. Biolegend will perform as the prime contractor, with all work taking place...

This federal contract award is for BIOLEGEND TOTALSEQ-C REAGENTS with a ceiling value of $48,965.00. The contract was awarded by the National Heart Lung and Blood Institute, a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and scientific research products located in San Diego, California. The contract is a firm fixed-price purchase order with an ultimate completion date of October 9, 2025. The contract does not have a small business set-aside designation. Biolegend, Inc. is a regular supplier of specialized biological research materials to various NIH institutes, supporting critical research areas such as COVID-19, immune response analysis, single-cell genomics, and studies on diseases like multiple sclerosis, cancer, and infectious diseases.

Generated 9/9/25, 12:54 PM